Seizure

The use of intravenous immunoglobulin (IVIG) therapy within neurology has been primarily limited to autoimmune disorders, with the goal of reversing or halting progressive neurological deterioration related to the underlying immune mediated attack on the nervous system.

The publisher regrets that the first and last names of the corresponding author and co-authors were transposed during publication. The correction has been applied to the online version and here.